Published in Blood Weekly, September 12th, 2002
Second quarter operating revenues of $46,000 and operating expenses of $6.2 million contributed to a net loss of $5.5 million, or $0.20 per share. In the second quarter of 2001, operating revenues of $94,000 and operating expenses of $11.1 million contributed to a net loss of $9.6 million, or $0.35 per share.
Cash, cash equivalents, and investments at June 30, 2002, totaled $101.4 million, compared with $112.3 million at December 31, 2001. These investments mature at various dates through May 17, 2004. As...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.